Women diagnosed with macromastia face a significantly elevated risk of developing chronic migraine, neck pain, and obstructive sleep apnea, according to a cross-sectional study published September 22, 2026, in the journal Headache. Researchers analyzing electronic health records for 687 women found that those with the condition—marked by excessive, disproportionate breast tissue enlargement—were 40% more likely to experience chronic migraine and roughly twice as likely to suffer from neck pain compared to peers without the diagnosis, even after adjusting for body mass index (BMI) and other confounding variables.
Medical Record Analysis Links Macromastia to Neurological and Sleep Disorders
Investigators at Wake Forest University School of Medicine and Stanford Medical Center reviewed medical records for 23,288 female patients treated at Stanford-affiliated headache and neurology clinics between 2017 and 2024. The final matched analysis included 347 women with a clinical diagnosis of macromastia and 340 women without the condition, with average ages of 58.1 and 57.0 years, respectively. Lead investigator Kristyn Pocock, MD, an assistant professor of neurology at Wake Forest, noted in a statement that while the condition is often viewed strictly as a cosmetic issue, the findings connect it to a broader suite of women’s health concerns.
To isolate the physical impact of enlarged breast tissue, the study controlled for age, BMI, race, ethnicity, marital status, and baseline rates of depression and anxiety. Depression and anxiety appeared notably higher among the macromastia cohort, affecting 48.4% and 57.3% of those patients, respectively, compared to 29.7% and 32.9% in the control group. Even with these adjustments, the elevated odds for specific neurological and musculoskeletal diagnoses remained statistically significant across the board.
Quantifying the Risk for Chronic Migraine and Cervical Radiculopathy
The data revealed distinct jumps in craniocervical pain disorders among women carrying the diagnosis. Women with macromastia showed an adjusted prevalence ratio (aPR) of 1.40 for chronic migraine, defined as a headache occurring on 15 or more days per month for over three months. The risk for localized physical pain proved even sharper: patients were roughly twice as likely to have neck pain (aPR, 2.04) and more than twice as likely to have cervical radiculopathy (aPR, 2.38), a painful condition driven by nerve compression or irritation in the neck. However, researchers found no significant association with occipital neuralgia.
According to the study authors, the extra mechanical load imposed by enlarged breast tissue on the cervical spine likely contributes to this nerve and muscle strain. Alongside musculoskeletal symptoms, obstructive sleep apnea (OSA) appeared 54% more frequently in the macromastia group (aPR, 1.54). While investigators suggest the physical presence of breast tissue may restrict breathing mechanics or correlate with lower physical activity levels, the cross-sectional design prevents the team from establishing a definitive cause-and-effect relationship.
Evaluating Breast Reduction Surgery Outcomes
The research team also evaluated whether surgical intervention altered patient symptom burdens. Among the conditions studied, neck pain stood out as the only issue significantly associated with having undergone breast reduction surgery, showing an aPR of 2.33 after adjustments. By contrast, chronic migraine, cervical radiculopathy, occipital neuralgia, and obstructive sleep apnea showed no statistically significant links to the procedure in this cohort.
Because the investigation relied on retrospective diagnostic codes, the authors cautioned that the data lack granular details regarding symptom severity, exact duration, and overall functional impact. Pocock and her colleagues emphasized that clinicians evaluating female patients with macromastia and chronic headaches should integrate formal headache phenotyping and routine screening for obstructive sleep apnea into their comprehensive clinical assessments.
Frequently Asked Questions About Macromastia and Health Risks
What is macromastia?
Macromastia, also known as breast hypertrophy, is a medical condition defined by the excessive, abnormal enlargement of one or both breasts that is disproportionate to the rest of the individual’s body frame.
How does macromastia affect neurological health?
The study published in Headache found that women with macromastia had a 40% higher prevalence of chronic migraine and were more than twice as likely to suffer from cervical radiculopathy due to mechanical strain on the cervical spine.
Does breast reduction surgery eliminate these symptoms?
The research found a significant association between breast reduction surgery and relief from neck pain, but chronic migraines, sleep apnea, and cervical radiculopathy were not significantly tied to having undergone the procedure within this specific patient group.
What are the next steps for this research?
Investigators are calling for prospective, longitudinal studies to track patients over time, which will help determine whether macromastia directly causes these neurological and sleep disorders and whether specific treatments can reduce symptom severity.
Worth a look